메뉴 건너뛰기




Volumn 21, Issue 4, 2012, Pages 441-442

HIV/HCV Coinfection in Romania - Can we afford not to treat?

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; FINANCIAL MANAGEMENT; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER FIBROSIS; LIVER TOXICITY; MIXED INFECTION; MORTALITY; PUBLIC HEALTH PROBLEM; ROMANIA; SURVIVAL; VIRUS LOAD;

EID: 84875073946     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (1)

References (7)
  • 1
    • 83255173840 scopus 로고    scopus 로고
    • Human immunodeficiency virus in injecting drug users in Europe following a reported increase of causes in Greece and Romania, 2011
    • Pharris A, Wiessing L, Sfetcu O, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of causes in Greece and Romania, 2011. Euro Surveil 2011; 16. pii: 20032.
    • (2011) Euro Surveil , vol.16 , pp. 20032
    • Pharris, A.1    Wiessing, L.2    Sfetcu, O.3
  • 2
    • 84875061705 scopus 로고    scopus 로고
    • CNLAS, Comisia Nationalǎ de Luptǎ Anti SIDA) available at
    • National Commission of Fighting against AIDS (CNLAS, Comisia Nationalǎ de Luptǎ Anti SIDA) available at: http://www.cnlas.ro/images/doc/romania31dec2011_eng.pdf
    • National Commission of Fighting Against AIDS
  • 3
    • 10344230440 scopus 로고    scopus 로고
    • Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial
    • Carrat F, Bani-Sadr F, Pol S, et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004; 292: 2839-2848.
    • (2004) JAMA , vol.292 , pp. 2839-2848
    • Carrat, F.1    Bani-Sadr, F.2    Pol, S.3
  • 4
    • 79952705520 scopus 로고    scopus 로고
    • HIV/HCV co-infection: Pathogenesis, clinical complications, treatment, and new therapeutic technologies
    • Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep 2011; 8: 12-22.
    • (2011) Curr HIV/AIDS Rep , vol.8 , pp. 12-22
    • Operskalski, E.A.1    Kovacs, A.2
  • 5
    • 53549115066 scopus 로고    scopus 로고
    • Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis
    • Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008; 22: 1979-1991.
    • (2008) AIDS , vol.22 , pp. 1979-1991
    • Thein, H.H.1    Yi, Q.2    Dore, G.J.3    Krahn, M.D.4
  • 6
    • 77954681429 scopus 로고    scopus 로고
    • Access to peginterferon plus ribavirin therapy for hepatitis C in Romania between 2002-2009
    • Gheorghe L, Pascu O, Ceausu E, et al. Access to peginterferon plus ribavirin therapy for hepatitis C in Romania between 2002-2009. J Gastrointestin Liver Dis 2010; 19: 161-167.
    • (2010) J Gastrointestin Liver Dis , vol.19 , pp. 161-167
    • Gheorghe, L.1    Pascu, O.2    Ceausu, E.3
  • 7
    • 77954760793 scopus 로고    scopus 로고
    • Canadian Co-infection Cohort Study Investigators. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy
    • Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB; Canadian Co-infection Cohort Study Investigators. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. AIDS 2010; 24: 1857-1865.
    • (2010) AIDS , vol.24 , pp. 1857-1865
    • Potter, M.1    Odueyungbo, A.2    Yang, H.3    Saeed, S.4    Klein, M.B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.